FAQs

Empowering individuals on their weight loss journey by providing accessible and effective alternatives to traditional weight loss treatments.

FAQ for Tesamorelin:

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that is used to reduce excess abdominal fat in individuals with lipodystrophy.

Tesamorelin is typically administered via a subcutaneous injection, usually once daily. It’s important to follow your healthcare provider’s instructions for the correct technique and site of injection.

To reconstitute, add 4 milliliters (4 x 1ml/100 unit syringe) of sterile water to the vial containing 10 milligrams of tesamorelin. This will give you a concentration of 2.5 milligrams per milliliter.

It is generally taken once daily, at a time that is convenient for you, but it’s recommended to be consistent with the time of day you take it.

The standard recommended dose is 1.4 milligrams once daily. This will be approximately 50 units on a 1ml (100 unit) syringe.

Dosages can vary, so it’s always best to do your own research.

THIS IS ONLY A GUIDE FOR RESEARCH AND NOT A RECOMMENDATION, PLEASE DO YOUR OWN RESEARCH.

FAQ for the 70mg Glow Blend peptide vial:

Glow Blend is a peptide combination that includes BPC-157, TB-500, and GHK-Cu, often used to support recovery, tissue repair, and overall skin, hair, and nail health.

To reconstitute, add 3 milliliters of bacteriostatic water to the vial containing 70 milligrams of the peptide blend. This will give you a concentration of about 23.33 milligrams per milliliter.

The typical dosage is about 15 units every other day, which equates to roughly 2.5mg GHK-CU and 0.5mg each of BPC157 and TB500.

It’s usually administered subcutaneously, often in the abdominal area or thigh. Rotate injection sites to minimize any discomfort.

It’s typically taken every other day, but the exact timing can be flexible. Consistency is key, so pick a time that works best for you.

Store the vial in the refrigerator after reconstitution to maintain its stability and potency.

Some users might experience mild redness or irritation at the injection site.

Dosages can vary, so it’s always best to do your own research.

THIS IS ONLY A GUIDE FOR RESEARCH AND NOT A RECOMMENDATION, PLEASE DO YOUR OWN RESEARCH.

FAQ for the AOD 9604:

AOD 9604 is a peptide that is often used for its potential fat-burning properties.

AOD 9604 is typically administered via subcutaneous injection. It's best taken 1st thing in the morning around half hour before breakfast, empty stomach.

To reconstitute AOD 9604, mix the 5mg peptide powder with 2ml of water for injections. Push the water into the vial slowly. If you push it in too fast, the solution can curdle.

AOD 9604 is usually taken once daily.

The recommended dose can vary, but it typically ranges from 200 to 600 micrograms per day. I suggest a good starting dose is 250mcg. This will be 10 units on a 1ml syringe.

Dosages can vary, so it’s always best to do your own research. I would also take it daily for 5 days and take 2 days off then start again the following week.

THIS IS ONLY A GUIDE FOR RESEARCH AND NOT A RECOMMENDATION, PLEASE DO YOUR OWN RESEARCH.

FAQ for the BPC-157:

BPC-157, or Body Protection Compound-157, is a synthetic peptide known for its potential to accelerate tissue healing and reduce inflammation.

Add 2ml of bacteriostatic water to the vial.

There isn't a universally accepted dosage, but anecdotal reports suggest a range of 200 to 750 micrograms per day, depending on the condition.

It can be administered subcutaneously (under the skin) or intramuscularly (into the muscle), depending on the targeted area.

It's generally used for healing purposes, so you might consider starting it if you have an injury or inflammation.

Store it in a refrigerator and keep it away from light. Use it within 6 weeks.

Possible side effects include nausea, dizziness, and injection site reactions.

Dosages can vary, so it’s always best to do your own research.

THIS IS ONLY A GUIDE FOR RESEARCH AND NOT A RECOMMENDATION, PLEASE DO YOUR OWN RESEARCH.